Abstract
BackgroundCorynebacterium crenatum SYPA 5 is the industrial strain for l-arginine production. Poly-β-hydroxybutyrate (PHB) is a kind of biopolymer stored as bacterial reserve materials for carbon and energy. The introduction of the PHB synthesis pathway into several strains can regulate the global metabolic pathway. In addition, both the pathways of PHB and l-arginine biosynthesis in the cells are NADPH-dependent. NAD kinase could upregulate the NADPH concentration in the bacteria. Thus, it is interesting to investigate how both PHB and NAD kinase affect the l-arginine biosynthesis in C. crenatum SYPA 5.ResultsC. crenatum P1 containing PHB synthesis pathway was constructed and cultivated in batch fermentation for 96 h. The enzyme activities of the key enzymes were enhanced comparing to the control strain C. crenatum SYPA 5. More PHB was found in C. crenatum P1, up to 12.7 % of the dry cell weight. Higher growth level and enhanced glucose consumptions were also observed in C. crenatum P1. With respect to the yield of l-arginine, it was 38.54 ± 0.81 g/L, increasing by 20.6 %, comparing to the control under the influence of PHB accumulation. For more NADPH supply, C. crenatum P2 was constructed with overexpression of NAD kinase based on C. crenatum P1. The NADPH concentration was increased in C. crenatum P2 comparing to the control. PHB content reached 15.7 % and 41.11 ± 1.21 g/L l-arginine was obtained in C. crenatum P2, increased by 28.6 %. The transcription levels of key l-arginine synthesis genes, argB, argC, argD and argJ in recombinant C. crenatum increased 1.9–3.0 times compared with the parent strain.ConclusionsAccumulation of PHB by introducing PHB synthesis pathway, together with up-regulation of coenzyme level by overexpressing NAD kinase, enables the recombinant C. crenatum to serve as high-efficiency cell factories in the long-time l-arginine fermentation. Furthermore, batch cultivation of the engineered C. crenatum revealed that it could accumulate both extracellular l-arginine and intracellular PHB simultaneously. All of these have a potential biotechnological application as a strategy for high-yield l-arginine.Electronic supplementary materialThe online version of this article (doi:10.1186/s12934-016-0414-x) contains supplementary material, which is available to authorized users.
Highlights
Corynebacterium crenatum SYPA 5 is the industrial strain for l-arginine production
L-arginine was produced by the catalysis of a series of enzymes encoded by the argCJBDFRJH cluster involved
We developed an approach to increase the NADPH availability in vivo through introducing NAD kinase, the key NADPH producing enzyme in C. crenatum, and were intended to see whether it had any effect on the l-arginine and PHB production or not
Summary
Corynebacterium crenatum SYPA 5 is the industrial strain for l-arginine production. It is interesting to investigate how both PHB and NAD kinase affect the l-arginine biosynthesis in C. crenatum SYPA 5. Arginine is a kind of semi-essential amino acid and plays a significant role in nitrogen metabolism and ammonia detoxification as an intermediate in the urea cycle in humans [1]. It is involved in numerous areas of application, such as food flavor, pharmacology and physiology [2, 3]. Much work has been done to increase the production of l-arginine using C. crenatum SYPA 5 as the start strain by adjusting the transfer efficiency for l-arginine, increasing the dissolved oxygen in bacterial, modifying the key enzymes involved in the l-arginine synthesis pathway [5, 10,11,12]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.